| abstract |
A terpene-enriched cannabinoid therapeutic product and methods for use thereof in treating conditions and/or symptoms associated with autism and/or autism spectrum disorder, the product including at least one cannabinoid, at least one primary terpene, and optionally at least three secondary terpenes, where the product has a therapeutic effect in treating conditions and/or symptoms associated with autism and/or autism spectrum disorder, and where said therapeutic effect is an enhanced therapeutic effect compared with that of a composition including the same cannabinoids amounts and one fifth the amount of said at least one primary terpene. |